# New AI Tool Boosts Precision Medicine in Treating CNS Cancers

Harvard Medical School researchers have developed an AI system that distinguishes glioblastoma from other brain tumors during surgery. The tool called PICTURE achieved 99.8% accuracy in differentiating glioblastoma from primary central nervous system lymphoma. This rare malignancy is frequently misdiagnosed as glioblastoma, yet the AI system outperformed nine human neuropathologists who misclassified lymphoma as glioblastoma in 38% of test cases.

 As such innovations improve brain cancer diagnosis, therapeutics developed by companies like CNS Pharmaceuticals Inc. (NASDAQ: CNSP) could stand a higher chance of…

 Read More>>

 NOTE TO INVESTORS: The latest news and updates relating to CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are available in the company’s newsroom at https://ibn.fm/CNSP

 About TinyGems

 TinyGems is a specialized communications platform with a focus on innovative small-cap and mid-cap companies with bright futures and huge potential. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TinyGems is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, TinyGems brings its clients unparalleled recognition and brand awareness. TinyGems is where breaking news, insightful content and actionable information converge.

 To receive SMS alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)

 For more information, please visit https://www.TinyGems.com

 Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer

 TinyGemsAustin, Texaswww.TinyGems.com512.354.7000 OfficeEditor@TinyGems.com

 TinyGems is powered by IBN 

---

[Original/Source Press Release](https://rss.investorbrandnetwork.com/tg/new-ai-tool-boosts-precision-medicine-in-treating-cns-cancers/)
                    

[Newsramp.com TLDR](https://newsramp.com/curated-news/harvard-ai-tool-revolutionizes-brain-cancer-diagnosis-during-surgery/f9a1be37f08fb7c0b650a1a378e45437) 


Pickup - [https://burstable.news/news](https://burstable.news/news/202510/250521-harvard-medical-school-ai-system-revolutionizes-brain-tumor-diagnosis-during-surgery)

Pickup - [https://estallarnoticias.com/](https://estallarnoticias.com//202510/250523-sistema-de-ia-de-harvard-medical-school-mejora-diagnostico-de-tumores-cerebrales-durante-cirugia)

Pickup - [https://platzennachrichten.de/nachrichten](https://platzennachrichten.de/nachrichten/202510/250640-ki-system-revolutioniert-diagnose-von-hirntumoren-wahrend-operationen)

Pickup - [https://actueclair.com](https://actueclair.com/202510/250628-un-outil-d-ia-revolutionnaire-ameliore-le-diagnostic-des-cancers-du-systeme-nerveux-central)
 

 



![Blockchain Registration](https://cdn.newsramp.app/ibn/qrcode/2510/13/airyIpVm.webp)